title: Miller Fisher's syndrome.
abstract: Miller Fisher's syndrome is a rare variant of Guillain-Barré's syndrome characterized by the acute development of ataxia, ophthalmoparesis, and areflexia. Most patients have a measureable antibody in serum directed against the GQ1b ganglioside. This antibody is also present in the serum of patients with other forms of Guillain-Barré's syndrome who have prominent ataxia or ophthalmoplegia as part of their clinical presentation. Miller Fisher's syndrome generally is self-limited and has an excellent prognosis.
authors.affiliation: Department of Neurology, University of Michigan Health System, Ann Arbor, MI 48109-5036, USA. jteener@med.umich.edu
authors.forename: James W
authors.initials: JW
authors.lastname: Teener
mesh_terms: D001259:Ataxia / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D001323:Autoantibodies / Q000097:blood*; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D019846:Miller Fisher Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D009886:Ophthalmoplegia / Q000276:immunology*; D012021:Reflex, Abnormal / Q000187:drug effects*; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D005732:Gangliosides; C039129:GQ1b ganglioside